Inventor · disambiguated record
Sivaram Pillarisetti
Also filed as: PILLARISETTI SIVARAM
35 granted patents·17 pending applications·343 citations·filing 1997–2024
97Inventor score
Files withREDDY US THERAPEUTICS INC19NEUROPN THERAPEUTICS INC4REDDYS LAB LTD DR4KHANNA ISH3LONG ISLAND JEWISH RES INST3
Top patents by PatentIndex Score
52 records- 0195US7169785B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2003·Granted Jan 30, 2007·58 cites·29 claims
- 0294US7112587B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2003·Granted Sep 26, 2006·50 cites·6 claims
- 0392US6589997B2Small-molecule modulators of hepatocyte growth factor/scatter factor activitiesLONG ISLAND JEWISH RES INST·Filed 2001·Granted Jul 8, 2003·35 cites·5 claims
- 0491US7163943B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2003·Granted Jan 16, 2007·34 cites·6 claims
- 0586US11844770B2Substituted cycloalkanes for managing nephrogenic diabetes insipidusNEPHRODI THERAPEUTICS INC·Filed 2021·Granted Dec 19, 2023·1 cites·72 claims
- 0686US7335656B2Medical devices employing triazine compounds and compositions thereofREDDY US THERAPEUTICS INC·Filed 2006·Granted Feb 26, 2008·4 cites·22 claims
- 0786US6610726B2Compositions and agents for modulating cellular proliferation and angiogenesisLONG ISLAND JEWISH RES INST·Filed 2001·Granted Aug 26, 2003·21 cites·12 claims
- 0885US7332488B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2006·Granted Feb 19, 2008·4 cites·20 claims
- 0985US6855728B2Small-molecule modulators of hepatocyte growth factor / scatter factor activitiesLONG ISLAND JEWISH RES INST·Filed 2003·Granted Feb 15, 2005·14 cites·6 claims
- 1084US7132423B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2003·Granted Nov 7, 2006·11 cites·6 claims
- 1183US7332490B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2006·Granted Feb 19, 2008·4 cites·24 claims
- 1282US7265114B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2005·Granted Sep 4, 2007·5 cites·39 claims
- 1381US7169784B2Medical devices employing triazine compounds and compositions thereofREDDY US THERAPEUTICS INC·Filed 2004·Granted Jan 30, 2007·11 cites·5 claims
- 1480US7173032B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2003·Granted Feb 6, 2007·14 cites·70 claims
- 1579US12433858B2Substituted cycloalkanes for managing nephrogenic diabetes insipidusNEPHRODI THERAPEUTICS INC·Filed 2023·Granted Oct 7, 2025·0 cites·72 claims
- 1679US11179354B2Substituted cycloalkanes for managing nephrogenic diabetes insipidusNEPHRODI THERAPEUTICS INC·Filed 2018·Granted Nov 23, 2021·1 cites·38 claims
- 1778US7989463B2Biccyclic compounds as GATA modulatorsREDDYS LAB LTD DR·Filed 2009·Granted Aug 2, 2011·4 cites·15 claims
- 1878US7268134B2Medical devices employing triazine compounds and compositions thereofREDDY US THERAPEUTICS INC·Filed 2004·Granted Sep 11, 2007·7 cites·5 claims
- 1978US6156315AMethod for inhibiting the binding of low density lipoprotein to blood vessel matrixUNIV COLUMBIA·Filed 1997·Granted Dec 5, 2000·32 cites·8 claims
- 2077US8623897B2Methods and compositions for treatment of diabetes and dyslipidemiaKHANNA ISH·Filed 2011·Granted Jan 7, 2014·5 cites·12 claims
- 2176US8008328B2Methods for the treatment of diabetes-associated dyslipdemiaREDDY US THERAPEUTICS INC·Filed 2007·Granted Aug 30, 2011·2 cites·11 claims
- 2275US7820654B2Pyrimidine compounds, process for their preparation and compositions containing themREDDYS LAB LTD DR·Filed 2005·Granted Oct 26, 2010·4 cites·9 claims
- 2374US8604055B2Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitorsBARUAH ANIMA·Filed 2006·Granted Dec 10, 2013·3 cites·31 claims
- 2471US9765030B2Benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitorsDr Reddys Laboratories Ltd·Filed 2013·Granted Sep 19, 2017·1 cites·32 claims
- 2571US7332489B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2003·Granted Feb 19, 2008·4 cites·26 claims
- 2670US12121515B2Piperidine urea derivatives as soluble epoxide hydrolase inhibitorsNEUROPN THERAPEUTICS INC·Filed 2023·Granted Oct 22, 2024·0 cites·24 claims
- 2770US7238692B2Medical devices employing triazine compounds and compositions thereofREDDY US THERAPEUTICS INC·Filed 2004·Granted Jul 3, 2007·4 cites·18 claims
- 2866US9782407B2Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitorsDr Reddys Laboratories Ltd·Filed 2015·Granted Oct 10, 2017·1 cites·7 claims
- 2966US2005096372A1Small-molecule modulators of hepatocyte growth factor/scatter factor activitiesFiled 2004·Application pending·0 cites
- 3065US2007004729A1Methods and compositions of novel triazine compoundsTIMMER RICHARD T·Filed 2006·Application pending·0 cites
- 3164US11998538B2Piperidine urea derivatives as soluble epoxide hydrolase inhibitorsNEUROPN THERAPEUTICS LLC·Filed 2022·Granted Jun 4, 2024·0 cites·25 claims
- 3263US7335770B2Triazine compounds and their analogs, compositions, and methodsREDDY U5 THERAPEUTICS INC·Filed 2004·Granted Feb 26, 2008·4 cites·1 claims
- 3362US2024294516A1Piperidine urea derivatives as soluble epoxide hydrolase inhibitorsNEUROPN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3461US2008275049A1Methods and Compositions for Upregulation of GATA ActivityREDDY US THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 3560US6900041B2Methods and compositions for the treatment of inflammatory diseasesREDDY US THERAPEUTICS INC·Filed 2001·Granted May 31, 2005·3 cites·27 claims
- 3660US2024140930A1Piperidine urea derivatives for treatment of neurodegenerative diseasesNEUROPN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3760US2024139172A1Piperidine urea derivatives for cancer therapyNEUROPN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3858US7273712B2Methods and compositions for detecting compounds that modulate inflammatory responsesREDDY US THERAPEUTICS INC·Filed 2001·Granted Sep 25, 2007·1 cites·12 claims
- 3957US6656699B2Methods and compositions for glycosidase assaysREDDY US THERAPEUTICS INC·Filed 2001·Granted Dec 2, 2003·1 cites·20 claims
- 4055US2007043051A1Methods and compositions of novel triazine compoundsTIMMER RICHARD T·Filed 2006·Application pending·0 cites
- 4153US2005118564A1Methods and compositions for identification and therapeutic use of genes involved in vascular and proliferative diseasesFiled 2003·Application pending·0 cites
- 4251US2010144722A1Novel heterocyclic compounds as gata modulatorsREDDYS LAB LTD DR·Filed 2009·Application pending·0 cites
- 4350US9040558B2Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitorsBARUAH ANIMA·Filed 2005·Granted May 26, 2015·0 cites·28 claims
- 4448US2014121267A1Methods and compositions for treatment of diabetes and dyslipidemiaKHANNA ISH·Filed 2014·Application pending·0 cites
- 4548US2014142178A1Methods and compositions for treatment of diabetes and dyslipidemiaKHANNA ISH·Filed 2014·Application pending·0 cites
- 4647US2008119571A1Compositions and methods to enhance reverse cholesterol transportREDDY US THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 4745US7700774B2Heterocyclic compounds and their pharmaceutical compositionsREDDYS LAB LTD DR·Filed 2005·Granted Apr 20, 2010·0 cites·11 claims
- 4844US2003036103A1Methods and compositions for diagnosis and treatment of vascular conditionsFiled 2002·Application pending·0 cites
- 4942US2006128702A1Heterocyclic and bicyclic compounds, compositions and methodsPAL MANOJIT·Filed 2005·Application pending·0 cites
- 5041US2002182587A1Methods and compositions for the treatment and prevention of smooth muscle cell proliferationFiled 2002·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Sivaram Pillarisetti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →